We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
Morgan Stanley on InterGlobe Aviation: Buy | Target Rs 3126
Morgan Stanley maintained a buy rating on InterGlobe Aviation with a target price of Rs 3126.
“The new aircraft order is planning for 2030-35 capacity expansion plans,” the brokerage said.
“Market share and margin trends have been the two key drivers. Bulk aircraft orders, six-year operating leases, and young fuel-efficient fleet have led to low unit costs,” it added.
CLSA on ICICI Lombard: Buy| Target Rs 1550
CLSA maintained a buy rating on ICICI Lombard with a target price of Rs 1550. Growing faster than the industry in all segments except motor.
The healthcare segment is the fastest on a high base and credit health a new area of growth. Suppressed profitability and new accounting methodology.
Jefferies on J.B.Chemicals & Pharmaceuticals: Initiate buy| Target Rs 2680
Jefferies initiated coverage on J.B.Chemicals & Pharmaceuticals with a target price of Rs 2680. The global investment bank is of the view that JB Pharma outperforms industry growth.
“The company has a predictable and sustainable earnings profile. Over FY23-26, it expects JB to witness 12%/17%/20% revenue/EBITDA/PAT CAGR,” it said.
“Key positives are – life cycle management of key brands, synergistic acquisitions, and targeted new launches. The export growth will be led by the contract manufacturing of Lozenges,” it added.
AnandRathi on Oil & Gas: Gujarat Gas, MRPL and Chennai Petro
AnandRathi maintained a buy rating on Gujarat Gas but hikes its 12-month target to Rs 586 from Rs 580 earlier. The global investment bank maintained a hold rating on MRPL and Chennai Petro with a target price of Rs 79 and 448 respectively.
“Indian refiners’ GRMs could come at premiums to the benchmark. Lower petrol and diesel retail prices closer to elections could lead to some downside,” it said. The brokerage firm sees more volume growth across segments.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)